Format

Send to

Choose Destination
Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E204-7. doi: 10.5489/cuaj.2447.

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Author information

1
Department of Urology, University of California, Davis, Sacramento, CA;
2
Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA;
3
Department of Pathology, University of California, Davis, Sacramento, CA.

Abstract

Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center